A recently published clinical case study conducted at the Central Hospital in Karlstad, Sweden, shows that long-term use of Bactiguard coated Foley (BIP Foley) catheters reduces catheter associated urinary tract infections (CAUTIs) and greatly improves the patient’s quality of life.
”Permanent use of Foley catheters is often associated with frequently recurring urinary tract infections, which have a significant negative impact on the patients’ wellbeing and quality of life. This study confirms that using BIP Foley catheters reduces the risk of infections and leads to pronounced health benefits for long-term users, who may be chronically dependent on catheterization,” says Jonas Östregård, SVP Sales & Marketing at Bactiguard.
The objective of the study was to investigate the effect of using BIP Foleys on a patient, permanently catheterized with suprapubic catheter. Despite several infection preventive approaches and attempts, the patient suffered from frequently recurring catheter related urinary tract infections (CAUTIs) for many years. These infections required antibiotic treatments and healthcare nearly every month. One month after switching to the BIP Foley catheter from Bactiguard, the CAUTI symptoms disappeared and the patient remained free of symptomatic CAUTIs and subsequent antibiotic treatment for the entire 2.5-year study period.
In addition, the patient was more satisfied with the comfort during insertion, use and removal of the BIP Foley catheters compared to the catheters previously used.
The study is published in Therapeutic Advances in Urology, read the full article: https://journals.sagepub.com/doi/pdf/10.1177/1756287219854915
Bactiguard’s Foley catheters have been procured for the following regions/county councils in Sweden: Stockholm, Skåne, Östergötland, Värmland, Halland, Kronoberg, Kalmar, Blekinge and Västra Götaland. These regions together account for about 70% of Sweden’s population.
For further information, please contact:
Cecilia Edström, CFO, mobile: +46 72 226 23 28
